Biosergen AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	90	93	124	45	45	152
Market Cap Growth	-4.71%	-25.43%	179.03%	0.12%	-70.75%	-
Enterprise Value	75	70	114	38	35	115
Last Close Price	38.40	39.52	53.00	88.00	105.00	542.00
PB Ratio	11.11	11.43	2.58	21.08	1.96	7.53
P/TBV Ratio	11.11	11.43	2.58	21.08	1.96	7.53
Net Debt / Equity Ratio	-1.89	-1.89	-1.05	-0.89	-1.29	-1.07
Quick Ratio	1.95	1.95	10.92	1.34	3.03	3.15
Current Ratio	1.95	1.95	11.01	1.42	3.07	3.19
Return on Equity (ROE)	-144.93%	-144.93%	-76.29%	-217.09%	-158.27%	-
Return on Assets (ROA)	-68.46%	-68.46%	-39.86%	-83.14%	-67.42%	-
Return on Capital Employed (ROCE)	-389.70%	-389.70%	-39.80%	-1288.50%	-149.70%	-202.10%
Earnings Yield	-45.27%	-43.98%	-15.42%	-60.62%	-76.43%	-27.04%
Buyback Yield / Dilution	2.13%	2.13%	-370.34%	-63.31%	-11.05%	74.16%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.